Spiramycin

Producers shown on SFDA

(Record date:27/08/2021）

Producers shown on EP

(Quoted from EP website；record date:27/08/2021）

Producer:Shangqiu Longxing Pharmaceutical Co., Ltd., registered and established in Shangqiu City, Henan Province on December 3, 2007, belongs to the non-metallic mineral products industry. The main industry is the non-metallic mineral products industry. Our company operates in the mode of production and processing, with 11-50 employees and a registered capital of 5 million yuan.

Staff size:About 50 persons

Registered capital:RMB 5 million

Producer:Wuxi Fortune Pharmaceutical Co., Ltd. adheres to the belidf of "pray for the health,improve the living condition, bless the people",devotes to developing and manufacturing APL and finished products,and provide better products and service.We have complete quality assurance system,advanced facility,providing good products,and perfect matching facilities.The company has been qualified by China GMP,EU GMP,ISO14001(envirinmental management system),and ISO18001(safety management system).We have good talent term with composition of high technology human resource,who work on the position,like management,R&D,development,manufacturing,and marketing. 

Staff size:200-299 persons
Registered capital:RMB 320 million

All production workshops of the company have successfully passed GMP certification; Domestic sales are distributed in East China, North China, South China, northeast, northwest and southwest, and exported to Europe, North America and Southeast Asia. The company has actively adjusted the product layout and optimized the product structure, and has formed three series of product chains with 6-APA, 7-ACA and 7-ADCA as the parent core, realizing the successful leap from traditional antibiotic production to semi synthetic antibiotic production.

Staff size:6000 persons

Registered capital:RMB 880 million 200 thousand

Producer:Topfond Pharmaceutical Co., Ltd.is a large-scale large-scale enterprise integrating the production and sales of finished products, chemical synthesis raw materials and biological fermentation raw materials, and pharmaceutical management. Comprehensive pharmaceutical company.

Topfond Pharmaceutical was founded in 1969. In December 2000, the A shares of Topfond  Pharmaceutical was listed on the Shanghai Stock Exchange. After more than 40 years of hard work, the company has grown from small to large, from weak to strong, and has now developed into a large pharmaceutical group with 5 subsidiaries, 4 production plants and 1 national technology development center. It has 4000 employees. There are more than 4 people with total assets of more than 4 billion yuan. The company's production scale of finished preparations and fermentation tonnage of antibiotic raw materials are among the best in the industry in the country. Joined China General Technology Group in August 2008. In July 2013, it successfully realized the merger and absorption of shares exchange with China National Pharmaceutical and Health Industry Co., Ltd., and was officially included in China Pharmaceutical Management.

Topfond Pharmaceutical produces and reserves more than 10 types and nearly 600 varieties and specifications of products. It has an oral solid preparation workshop with an annual production capacity of nearly 6 billion tablets (tablets), the scale is among the forefront of the industry; the antibiotic fermentation tonnage is 12,000m³. The raw materials and some preparation products are exported to more than 20 countries and regions including Western Europe, Southeast Asia, the Middle East, North Africa, India, etc., and an international marketing network is initially formed.

Staff size:2000-2999 persons

Registered capital:RMB 420 million